Glaxosmithkline Share Price | |
---|---|
Price | 1,635.50 |
Bid | 1,635.50 |
Ask | 1,636.00 |
Change | -5.00 (-0.30%) |
Volume | 561,475 |
Open | 1,638.50 |
High | 1,647.00 |
Low | 1,635.00 |
Prev. Close | 1,640.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.09b |
Market Capitalisation | £66.83b |
Market Size | 1,500 |
52 Week High | 1,719.80 |
52 Week High Date | 07-Mar-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 2,169 |
---|---|
Vol. Sold | 240,394 |
Sold Value | £3.95m |
Vol. Bought | 318,931 |
Bought Value | £5.24m |
PE Ratio | 13.44984 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.393% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 11:12:19 | 1,635.75 | 2 | Sell* | 1,635.50 | 1,636.50 | 32.72 | O Ordinary |
26-Apr-24 | 11:12:16 | 1,636.00 | 100 | Buy* | 1,635.50 | 1,636.00 | 1,636 | A Automatic Execution |
26-Apr-24 | 11:12:05 | 1,635.50 | 100 | Buy* | 1,635.00 | 1,635.50 | 1,636 | A Automatic Execution |
26-Apr-24 | 11:12:05 | 1,635.00 | 417 | Buy* | 1,634.50 | 1,635.00 | 6,818 | A Automatic Execution |
26-Apr-24 | 11:12:05 | 1,635.00 | 213 | Buy* | 1,634.50 | 1,635.00 | 3,483 | A Automatic Execution |
26-Apr-24 | 11:12:05 | 1,635.00 | 194 | Buy* | 1,634.50 | 1,635.00 | 3,172 | A Automatic Execution |
26-Apr-24 | 11:12:05 | 1,635.00 | 100 | Buy* | 1,634.50 | 1,635.00 | 1,635 | A Automatic Execution |
26-Apr-24 | 11:12:00 | 1,635.00 | 276 | Sell* | 1,635.00 | 1,635.50 | 4,513 | A Automatic Execution |
26-Apr-24 | 11:11:29 | 1,635.75 | 2,059 | Buy* | 1,635.00 | 1,636.00 | 33.68k | O Ordinary |
26-Apr-24 | 11:11:06 | 1,635.75 | 121 | Buy* | 1,635.00 | 1,636.00 | 1,979 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
19-Apr-24 | 16-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 39.79 | USD | 2,906,213 | 3,370,704 |
19-Apr-24 | 16-Apr-24 | Buy Dividends | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 1,611.28 | GBX | 1,840,922 | 2,190,842 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Anne Beal held the position of Independent Non-Executive Director at the time of this trade.Anne Beal | 40.96 | USD | 9 | 3,375 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Harry (Hal) C. Dietz held the position of Independent Non-Executive Director at the time of this trade.Harry (Hal) C. Dietz | 40.96 | USD | 9 | 3,118 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 40.96 | USD | 13 | 464,491 |
At GSK, we unite science, technology and talent to get ahead of disease together